Lidocaine hydrochlo

DLA Troop Support Medical, through contracting office SPE2DP, seeks quotes under request for quotation SPE2DP27T0282 for line item 0001, one package (PG) of Lidocaine Hydrochloride and Dextrose Injection (NSN 6505-01-194-7265), with quotes due November 17, 2026. The Set Aside line reads "No Set-Aside Used," so the procurement is open to all sources. The NAICS code is 325412, with small business size standards applied, and the PSC is 6505, Drugs and Biologicals.

The item is 0.4% lidocaine and 5% dextrose, 500 mL premixed bags. Delivery is required within 20 days to March Air Reserve Base, California (FM6615, 452 MDG SGAL), on FOB Destination terms with inspection at destination. Quotes must be submitted via DIBBS, and the solicitation type is Fast Auto Evaluation.

Requirements include FDA regulatory compliance, commercial packaging per ASTM D3951 or hazardous material standards, at least 16 months of shelf life remaining at delivery, and compliance with Medical Marking Standard No. 1. The solicitation is governed by the DLA Master Solicitation for Automated Simplified Acquisitions, Revision 106 (November 3, 2026). Quoters must comply with Buy American Act and Berry Amendment restrictions, domestic material requirements, and covered telecommunications equipment prohibitions.

The source reports a manufacturer shortage from manufacturing delays and increased demand, with Baxter holding limited supplies. Historical procurements for this item span 2007 to 2026, with unit costs ranging from $59.71 to $179.00.